Side-effects of ibrutinib in relapsed/refractory mantle cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 1:31 8 years ago 974 Скачать Далее
Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma - Blood Cancers Video Library GRACE - Global Resource for Advancing Cancer Education 7:19 1 year ago 67 Скачать Далее
Ibrutinib vs temsirolimus in relapsed/refractory mantle cell lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 4:01 8 years ago 162 Скачать Далее
Relapsed/Refractory Mantle Cell Lymphoma Lymphoma Research Foundation 7:51 1 year ago 963 Скачать Далее
Ibrutinib Beats Temsirolimus in Relapsed/Refractory MCL American Society of Hematology 6:11 8 years ago 472 Скачать Далее
Acalabrutinib & Zanubrutinib for Relapsed/Refractory Mantle Cell Lymphoma - Blood Cancers Library GRACE - Global Resource for Advancing Cancer Education 4:40 1 year ago 123 Скачать Далее
Update on Relapsed/Refractory Mantle Cell Lymphoma | LRF Webinars Lymphoma Research Foundation 1:20:06 2 years ago 2 226 Скачать Далее
Real-World Data for Ibrutinib in Relapsed/Refractory MCL Targeted Oncology 1:27 5 years ago 117 Скачать Далее
Ibrutinib resistance-mechanisms and options in CLL HMP Education 29:14 7 years ago 3 369 Скачать Далее
Dr. Lee on Early Efficacy Data With Cirmtuzumab/Ibrutinib in Relapsed/Refractory MCL OncLive 1:25 4 years ago 376 Скачать Далее
Debate: Relapsed Mantle Cell Lymphoma - Ibrutinib based Therapy Alone HMP Education 11:45 3 years ago 338 Скачать Далее
Long-term ibrutinib outcomes vs. prior regimens: pooled analysis in R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:35 4 years ago 219 Скачать Далее
How to Treat Patients With Relapsed/Refractory Mantle Cell Lymphoma Targeted Oncology 1:56 4 years ago 253 Скачать Далее
Lori Leslie, MD, considers the use of zanubrutinib in relapsed/refractory mantle cell lymphoma OBRoncology 0:47 4 years ago 56 Скачать Далее
Debate: Optimal approach for the management of CLL patients with del(17p) - Novel Agents HMP Education 13:55 8 years ago 289 Скачать Далее
